Wet-Age Related Macular Degeneration
Wet-Age Related Macular Degeneration Market

Wet Age-related Macular Degeneration (Wet AMD) is a type of Age-related Macular Degeneration (AMD) characterized by sudden central vision loss caused by abnormal blood vessels, which bleed or leak fluid that may swell and damage the macula. Age-related Macular Degeneration is among the most prominent causes of severe, irreversible blindness globally, profoundly affecting individuals' quality of life. Wet AMD is also referred to as neovascular AMD.


Wet Age-related Macular Degeneration Epidemiological Segmentation

The Epidemiological Segmentation of Wet Age-related Macular Degeneration in 7MM from 2018 to 2030 is segmented into:-


  • Total Prevalent Cases of Wet Age-related Macular Degeneration
  • Gender-specific Cases of Wet Age-related Macular Degeneration
  • Age-specific Cases of Wet Age-related Macular Degeneration


Wet Age-related Macular Degeneration Epidemiological Insights Observed in 2020


  • The total diagnosed Wet Age-related Macular Degeneration prevalent population in 7MM was 4,426,968.
  • In the US, Wet Age-related Macular Degeneration was Gender-specific prevalent cases observed in males were 539,922, whereas, in females, 1,002,711 cases were observed. 
  • The prevalent cases of Wet Age-related Macular Degeneration in the United States were 1,542,633.
  • The Wet Age-related Macular Degeneration prevalent cases in Japan were 813,974.
  • The number of Wet Age-related Macular Degeneration prevalent cases in Germany was observed to be 563,881.
  • The number of Wet Age-related Macular Degeneration prevalent cases in Italy was 419,403.


Wet Age-related Macular Degeneration Market

In 2020, it was observed that the market size of Wet Age-related Macular Degeneration was expected to reach USD 7,459 million across the 7MM during the study period (2018–2030).


Wet Age-related Macular Degeneration Market Drivers


  • Drugs in pipeline
  • Personalized treatment
  • Increased prevalence 
  • Genetic therapy


 Wet Age-related Macular Degeneration Market Barriers


  • Cost of therapy
  • Launch of biosimilars
  • Future competition among similar drugs


Wet Age-related Macular Degeneration Emerging Drugs

The emerging drugs of the Wet Age-related Macular Degeneration market are


  • Faricimab
  • Conbercept
  • KSI-301
  • OPT-302
  • AKST4290
  • Sunitinib Malate
  • RGX-314
  • PAN-90806
  • Axitinib
  • HMR59
  • RBM-007 and others.


Wet Age-related Macular Degeneration Key Players

The key players working in the Wet Age-related Macular Degeneration market are 


  • Roche
  • Chengdu Kanghong Biotech
  • Kodiak Sciences Inc.
  • Opthea Limited
  • Alkahest Inc.
  • Graybug Vision
  • REGENXBIO
  • PanOptica, Inc.
  • Clearside Biomedical
  • Hemera Biosciences
  • Ribomic USA Inc. and others.